Document:

Amended and Restated Change of Control Severance Benefit Plan

 EXHIBIT 10.9 
 NEKTAR THERAPEUTICS 
 AMENDED AND RESTATED CHANGE OF CONTROL 
 SEVERANCE BENEFIT PLAN 
 PLAN
DOCUMENT AND SUMMARY PLAN DESCRIPTION 

 TABLE OF CONTENTS 
  

					
	 	 	 	  	PAGE
	Section 1.	 	Introduction	  	1
			
	Section 2.	 	Eligibility For Participation in the Plan	  	1
			
	Section 3.	 	Eligibility For Separation Benefits	  	1
			
	Section 4.	 	Separation Benefits	  	5
			
	Section 5.	 	Notices	  	7
			
	Section 6.	 	Claims	  	7
			
	Section 7.	 	Plan Amendment and Termination	  	9
			
	Section 8.	 	Legal Rights Under ERISA	  	9
			
	Section 9.	 	Other Important Information	  	10
			
	Section 10.	 	Important Plan Information	  	12

  

 i 

 NEKTAR THERAPEUTICS 
 AMENDED AND RESTATED 
 CHANGE OF CONTROL SEVERANCE BENEFIT PLAN 
 PLAN DOCUMENT AND SUMMARY PLAN DESCRIPTION 
 Section 1. Introduction  
 The Nektar Therapeutics Amended and Restated Change of Control Severance Benefit Plan (the
“Plan”) is designed to provide severance benefits to eligible employees of Nektar Therapeutics (the “Company” or “Nektar”) whose employment is involuntarily terminated by the Company following a Change of Control (as
defined below). The Plan was initially approved by the Board of Directors on December 6, 2006 and subsequently amended and restated and approved by the Board of Directors on February 14, 2007. The Plan supersedes any prior plan, policy or
practice involving the payment of severance benefits by Nektar in the event of an involuntary termination that occurs following a Change of Control. While the Plan is in effect, any severance benefits provided to an employee by the Company with
respect to an employee’s involuntary termination following a Change of Control must be paid pursuant to the Plan or pursuant to an express written agreement between Nektar and the individual employee. 
 The Plan is designed to be an “employee welfare benefit plan,” as defined in Section 3(1) of the Employee Retirement Income Security Act of 1974, as
amended (“ERISA”) and, accordingly, this Plan is governed by ERISA. This document constitutes both the official plan document and the required summary plan description under ERISA. 
 Section 2. Eligibility For Participation in the Plan  
 Each employee of the Company is eligible to participate in the Plan; provided, however, that an employee who has an individual agreement with the Company providing for severance benefits with respect to termination of employment with the
Company in connection with or following a Change of Control that would otherwise be covered by this Plan shall not be eligible to participate in this Plan (i.e. an eligible employee cannot receive severance benefits both under their individual
agreement and this Plan), and an individual who is not treated as an employee of the Company for payroll and income tax withholding purposes or who is treated as a consultant or independent contractor, regardless of a court or agency’s
determination of employee status of such person during any period for any purpose, shall not be eligible to participate in this Plan. 
 Section 3.
Eligibility For Severance Benefits  
 3.1 Conditions for Eligibility. To be eligible to receive severance benefits under the Plan, in
addition to meeting the requirements for eligibility to participate in the Plan, the participant must terminate employment with the Company under circumstances that the Plan Administrator determines constitute a Covered Termination, and the
participant must meet the following conditions: 

	•	 	 The participant must execute a Separation and General Release Agreement satisfactory to the Plan Administrator and within the time period established by the Plan
Administrator, which includes any or all of the following provisions: (i) the participant’s agreement to cooperate with the orderly transfer of his or her duties as requested by the Company or a Successor Company; (ii) the
participant’s agreement to return all Company and Successor Company property by a date specified by the Plan Administrator; (iii) the participant’s agreement to continue to maintain the confidentiality of Company and Successor Company
proprietary and confidential information; (iv) the participant’s agreement to adhere to a non-solicitation restriction; and (v) the participant’s waiver and general release of all claims with respect to the Company and Successor
Company and related parties, including the right to pursue any type of legal, equitable, or administrative claim, except for claims that by law are unwaivable. All separation benefits payable under the Plan are conditioned on any waiver of claims
included in the Separation and General Release Agreement becoming effective and irrevocable and the participant’s satisfaction of his or her obligations under such agreement. 

  

	•	 	 If the participant is notified by the Company or Successor Company that his or her employment will be terminated following a Change of Control in advance of his or
her termination date, the participant must not voluntarily terminate his or her employment or fail to perform his or her assigned duties prior to the termination date established by the Company or Successor Company. 

  

	•	 	 The participant must not at any time have engaged in conduct that would be Cause for termination, as defined in Section 3.3 below, as determined by the Plan
Administrator in its sole discretion. The Plan Administrator shall have the discretion to terminate any and all severance benefits provided under this Plan to a participant who is discovered to have engaged in such conduct, regardless of when such
discovery occurs. 

 3.2 Covered Termination. For purposes of this Plan, a Covered Termination is an involuntary termination of the
participant’s employment with the Company or Successor Company in conjunction with a Change of Control under the circumstances described below applicable to the participant, as follows: 
  

	•	 	 For a participant who is an officer holding a position of Executive Chairman, Chief Executive Officer, President, Chief Operating Officer, Business Unit Head, Chief
Scientific Officer, Chief Technical Officer, Chief Financial Officer, Senior Vice President, Vice President or Principal Fellow (an “Officer Participant”), a Covered Termination is the involuntary termination of the participant’s
employment by the Company or Successor Company without Cause, other than on account of the participant’s death or disability, or the participant’s Good Reason Resignation, which (i) termination occurs at the request of a third party
in the context of discussions regarding a Change of Control or (ii) termination or resignation occurs within the period beginning with the execution of an agreement providing for a Change of Control (and such Change of Control is consummated)
and ending 12 months following the Change of Control. 

  

 2 

	•	 	 For any other participant (a “Non-Officer Participant”), a Covered Termination is the involuntary termination of the participant’s employment by the
Company or Successor Company without Cause, other than on account of the participant’s death or disability, which termination or resignation occurs within the period beginning on the date of the Change of Control and ending 12 months following
the Change of Control. 

 Notwithstanding the foregoing, a termination of the participant’s employment shall not be considered a
Covered Termination in the event the participant is offered and declines a Comparable Position (as defined below) with the Company or Successor Company unless the failure to provide such participant at the Successor Company with the officer or
director position he or she held in the Company prior to the Change of Control constitutes a Good Reason Resignation pursuant to the terms hereof. A participant who is offered a Comparable Position who does not accept such position within 30 days
(or such greater time for acceptance specified in a written offer) will be deemed to have declined such Comparable Position. For purposes of this Section 3.2, a “Comparable Position” means a position with the following attributes:
(i) monthly base salary equal to the employee’s monthly base salary immediately prior to termination, or combination of monthly base salary plus annual target incentive pay equal to the employee’s monthly base salary plus annual
target incentive pay for the employee’s immediately previous position provided that the monthly base salary is not lower than 10% of that received by the employee in his or her immediately previous position; (ii) assignment to a work
location no more than 50 miles from the participant’s immediately previous work location; and (iii) assignment of duties or responsibilities that do not constitute a material diminution in the participant’s immediately previous
function with respect to the business of the Company. 
 3.3 Cause. For purposes of this Plan, Cause shall mean, as determined by the Plan
Administrator: 
  

	•	 	 An employee’s conviction of any felony or any crime involving fraud, dishonesty or moral turpitude; 

  

	•	 	 An employee’s commission of, or participation in, a fraud or act of dishonesty against the Company or Successor Company that materially benefits the employee;

  

	•	 	 An employee’s intentional, material violation of any contract or agreement between the employee and the Company or Successor Company or of any statutory or
fiduciary duty owed to the Company or Successor Company; 

  

	•	 	 An employee’s intentional unauthorized use of Company or Successor Company property that materially benefits the employee or intentional unauthorized use or
disclosure of Company or Successor Company confidential information or trade secrets; 

  

	•	 	 An employee’s intentional gross misconduct or intentional material failure to comply with the Company’s or Successor Company’s written policies; or

  

	•	 	 An employee’s intentional material failure or refusal to perform his or her position responsibilities, other than on account of a mental or physical
disability. 

  

 3 

 No act or failure to act on the part of an individual shall be considered “intentional” unless done, or omitted
to be done, by that individual not in good faith and without reasonable belief that such individual’s action or omission was in the best interest of the Company. In no event shall mere failure to achieve desired strategic, operational,
financial or other results constitute Cause. 
 3.4 Good Reason Resignation. For purposes of this Plan, an Officer Participant’s Good Reason
Resignation shall mean a voluntary resignation by the Officer Participant within 60 days following one or more of the following events with respect to the Officer Participant: 
  

	•	 	 Assignment of any duties or responsibilities that results in a material diminution in the participant’s function as in effect immediately prior to the Change
of Control. 

  

	•	 	 Assignment to a work location more than 50 miles from the participant’s immediately previous work location, unless such reassignment of work location decreases
the participant’s commuting distance from his or her residence to his or her assigned work location. 

  

	•	 	 More than a 10% decrease in the participant’s monthly base salary as in effect on the date of the Change of Control or as increased thereafter.

  

	•	 	 Notice to the participant by the Company or Successor Company that the participant’s employment will be terminated under circumstances that would be a Covered
Termination but for the designation of a date for termination that is greater than 12 months following the Change of Control. 

  

	•	 	 In the case of the Chief Executive Officer and President, such individual does not serve in that position in the Successor Company (as defined below) and/or is not
appointed to the board of directors of the Successor Company. 

 3.5 Change of Control. A Change of Control with respect to the
Company shall mean any of the following events or circumstances: 
  

	•	 	 The sale, lease or other disposition of all or substantially all of the Company’s assets; 

  

	•	 	 The acquisition of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities, other than
by virtue of a merger, consolidation or similar transaction; 

  

	•	 	 The merger, consolidation or similar transaction involving the Company, immediately after which the stockholders of the Company immediately prior thereto do not own
either (i) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving entity in such merger, consolidation or similar transaction or (ii) more than 50% of the combined outstanding
voting power of the parent of the surviving entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their ownership of the outstanding voting securities of the Company immediately prior to
such transaction; or 

  

 4 

	•	 	 Individuals who, on the date the Plan is adopted by the Board, are members of the Board (the “Incumbent Board”) cease for any reason to constitute at
least a majority of the members of the Board, provided, however, that if the appointment or election of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member
will, for purposes of the Plan, be considered as a member of the Incumbent Board. 

 In the event of a Change of Control following which
Nektar is not the surviving entity, the surviving entity for purposes of this Plan is the “Successor Company.” 
 Section 4. Severance
Benefits  
 4.1 Cash Severance Pay; Amount. The amount of a participant’s Cash Severance Pay benefit under this Plan shall be determined
based on position title as follows, and then reduced as specified below: 
  

	•	 	 Executive Chairman: Cash Severance Pay shall equal 24 months of monthly base salary plus annual target incentive pay as in effect immediately prior to the Covered
Termination or for the immediately preceding calendar year, whichever is greater. 

  

	•	 	 Chief Executive Officer and President: Cash Severance Pay shall equal 24 months of monthly base salary plus annual target incentive pay as in effect immediately
prior to the Covered Termination or for the immediately preceding calendar year, whichever is greater. 

  

	•	 	 Chief Scientific Officer, Chief Financial Officer, Chief Technical Officer, Chief Operating Officer and Business Unit Head: Cash Severance Pay shall equal 12 months
of monthly base salary plus annual target incentive pay as in effect immediately prior to the Covered Termination or for the immediately preceding calendar year, whichever is greater. 

  

	•	 	 Senior Vice Presidents, Vice Presidents and Principal Fellows: Cash Severance Pay shall equal 12 months of monthly base salary plus annual target incentive pay as
in effect immediately prior to the Covered Termination or for the immediately preceding calendar year, whichever is greater. 

  

	•	 	 All Other Participants: Cash Severance Pay shall equal 6 months of monthly base salary plus annual target incentive pay as in effect immediately prior to the
Covered Termination or for the immediately preceding calendar year, whichever is greater. 

 Cash Severance Pay shall be reduced by each of
the following: 
  

	•	 	 any wages or wage replacement benefits paid or payable to the participant with respect to any applicable notice period (including any pay in lieu of notice) in
connection with the participant’s termination of employment, whether such notice period is required under the 

  

 5 

	 	 
Worker Adjustment and Retraining Notification Act or any state law with respect to notice, if applicable, or any Company policy, or any written agreement
between the participant and the Company; 

  

	•	 	 the amount of any wages or other compensation the participant has received during a leave of absence in excess of his or her accrued paid time off (other than
disability plan income replacement benefits); and 

  

	•	 	 to the extent permitted by law, by any debt that the participant owes the Company at the time the severance pay benefit becomes payable.

 4.2 Cash Severance Pay: Time of Payment. The Severance Pay for which a
participant is eligible under this Plan will be paid to the participant in a lump sum cash payment no later than the next regular Company or Successor Company payroll date for the payroll period commencing immediately after the effective date of the
participant’s Separation and General Release Agreement described above, as specified in such Separation and General Release Agreement, and the participant’s satisfaction of all conditions for payment set forth in the Separation and General
Release Agreement. Notwithstanding the foregoing, (i) the payment to an Officer Participant (and any other participant if the participant is a “specified employee” within the meaning of Code Section 409A) shall automatically be
delayed to the next payroll date following the 181st day after the termination of the Officer Participant’s employment with the Company or Successor
Company; and (ii) the payment to an Officer Participant will be delayed in the event the Company reasonably anticipates that the Company’s deduction with respect to such payment otherwise would be limited or eliminated by application of
Code Section 162(m) and such payment shall be made, subject to clause (i), at the earliest date that the Company reasonably anticipates that the deduction of the payment will not be limited or eliminated by application of Code
Section 162(m). 
 4.3 COBRA Premiums. For an eligible participant who is covered by one or more of the Company’s group health plans
on the date of termination of employment and who makes a timely election to continue such coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), the Company will pay the portion of such participant’s COBRA
premium equal to the portion of such group health plan premium cost the Company pays for active employees for the number of months base salary represented by the participant’s Cash Severance Pay determined under Section 4.1; provided that
such payment of a portion of the COBRA premium by the Company shall cease earlier on the date the participant becomes eligible for group medical, dental or vision coverage through a subsequent employer. 
 4.4 Outplacement Program. An eligible participant shall receive reimbursement for reasonable outplacement services up to a maximum of $5,000 for services received
within 12 months following termination. 
 4.5 Withholding. All cash and reimbursement severance benefits provided under the Plan will be subject to
all applicable withholding deductions as required by law. 
  

 6 

 4.6 Equity Acceleration. An eligible participant will become fully vested in any outstanding stock awards held by
such participant as of the date of termination, including restricted stock and stock options. 
 4.7 Limitation on Benefits Subject to Parachute
Rules. Notwithstanding Section 4.1 and 4.6, in the event the severance benefits payable to a participant who is a “disqualified individual” within the meaning of Code Section 280G, together with all other payments to which
such participant is entitled in connection with a Change of Control, would cause any portion of the payments to be nondeductible under Code Section 280G and subject to the excise tax imposed under Code Section 4999, then: (i) the
participant’s severance benefits will be reduced up to 10%, first with respect to the amount of the severance pay described in Section 4.1 and then with respect to all other severance benefits for which such participant is eligible under
this Plan, so as to reduce the payment to an amount not subject to the excise tax under Code Section 4999, to the extent such reduction will result in such participant’s receipt of a greater after-tax payment than the participant would
receive in the absence of such reduction and with the application of the excise tax under Code Section 4999, or (ii) if after reducing severance payments by up to 10%, the excise tax under Code Section 4999 is still applicable to
participant’s severance benefits, the Company will then cover all of the excise tax amounts imposed by Code Section 4999 on a grossed-up basis; provided however, the Company will not pay for any other taxes imposed on participant’s
severance benefits. 
 Section 5. Notices  
 Any notice or other communication under the Plan must be in writing and will be deemed given when delivered personally or when sent by certified or registered mail, return receipt requested, or by overnight courier, addressed as follows or
to such other address as any party may hereafter designate in accordance with this provision: 
 If to Nektar or the Plan
Administrator: 
 Nektar Therapeutics 
 150 Industrial Road 
 San Carlos, CA 94070 
 Attn: Vice President, Human Resources 
 If to the participant: to the address appearing in the payroll records of the Company. 
 Section 6. Claims  
 6.1 Initial Claims Procedure.
Any employee who does not receive a benefit under the Plan that he or she feels he or she is entitled to receive may make a written claim to the Plan Administrator within 90 days after his or her termination, in accordance with the Notice provisions
described above, and which explains the reasons for such claim. The claimant will be informed of the Plan Administrator’s decision with respect to the claim within 90 days after it is filed. Under special circumstances, the Plan Administrator
may require an additional period of not more than 90 days to review the claim. If that happens, the claimant will receive a written 

  

 7 

 
notice of that fact, which will also indicate the special circumstances requiring the extension of time and the date by which the Plan Administrator expects
to make a determination with respect to the claim. If the extension is required due to the claimant’s failure to submit information necessary to decide the claim, the period for making the determination will be tolled from the date on which the
extension notice is sent until the date on which the claimant responds to the Plan Administrator’s request for information. 
 6.2 Notice of Claim
Determination. If a claim is denied in whole or in part, or any adverse benefit determination is made with respect to the claim, the claimant will be provided with a written notice setting forth the reason for the determination, along with
specific references to Plan provisions on which the determination is based. This notice will also provide an explanation of what additional information is needed to evaluate the claim (and why such information is necessary), together with an
explanation of the Plan’s claims review procedure and the time limits applicable to such procedure, as well as a statement of the claimant’s right to bring a civil action under Section 502(a) of ERISA following an adverse benefit
determination on review. If an internal rule, guideline, protocol, or other similar criterion was relied upon in making the determination, the notice will either provide that rule, guideline, protocol or other similar criterion or will contain a
statement that it will be provided upon request. 
 6.3 Claims Appeal Procedure. If the claim has been denied, and the claimant wishes to pursue the
claim further, the claimant must request that the Plan Administrator review the denial. The request must be in writing and must be made within 60 days after written notification of denial. In connection with this request, the claimant may review
documents pertinent to the claim (other than those that are legally privileged) and may submit to the Plan Administrator written comments, documents, records, and other information related to the claim. 
 The review by the Plan Administrator will take into account all comments, documents, records, and other information that the claimant submits relating to the claim. The
Plan Administrator will make a final written decision on a claim review, in most cases within 60 days after receipt of a request for a review. In some cases, the claim may take more time to review, and an additional processing period of up to 60
days may be required. If that happens, the claimant will receive a written notice of that fact, which will also indicate the special circumstances requiring the extension of time and the date by which the Plan Administrator expects to make a
determination with respect to the claim. If the extension is required due to the claimant’s failure to submit information necessary to decide the claim, the period for making the determination will be tolled from the date on which the extension
notice is sent to the claimant until the date on which the claimant responds to the Plan’s request for information. 
 6.4 Notice of Appeal
Determination. The Plan Administrator’s decision on the claim for review will be communicated to the claimant in writing. If an adverse benefit determination is made with respect to the claim, the notice will include (i) the specific
reason(s) for any adverse benefit determination, with references to the specific Plan provisions on which the determination is based; (ii) a statement that the claimant is entitled to receive, upon request and free of charge, reasonable access
to (and copies of) all documents, records and other information relevant to the claim (other than those that are legally privileged); and (iii) a statement of the claimant’s right to bring a civil action under Section 502(a) of ERISA.
If an internal rule, guideline, protocol, or 

  

 8 

 
other similar criterion was relied upon in making the determination, the notice will either provide that rule, guideline, protocol or other similar criterion
or will contain a statement that it will be provided upon request. The decision of Plan Administrator is final and binding on all parties. 
 6.5
Requirement to Follow Claims Procedures. If a claimant does not file his or her claim in accordance with the Plan’s claim procedures described above, including applicable time limits, the claimant will not be entitled to benefits under
this Plan. 
 6.6 Limitation on Legal Action. No legal action with respect to this Plan may be brought until a claimant has exhausted the claims
procedures described above, including the claims appeal procedure. No legal action for coverage or benefits under the Plan may be commenced or maintained more than 2 years after the circumstances giving rise to the claim arose or, if earlier, 1 year
after the claims procedures, including the claims appeal procedure, is exhausted. 
 Section 7. Plan Amendment and Termination 

The Company reserves the right to amend or modify the Plan at any time, and in any respect, by action of its duly authorized officer, with or without prior notice to,
and effective with respect to, employees who may become eligible to participate in the Plan or become eligible for benefits under the Plan in the case of a reduction in benefits payable under the Plan, or who may otherwise have become eligible to
participate in the Plan in the case of an amendment that excludes such employees from eligibility to participate under the Plan. However, no such amendment or termination will be effective to: (i) decrease benefits under the Plan for which an
employee has already met all of the eligibility criteria and payment conditions set forth herein or (ii) negatively or adversely impact the rights of the Chief Executive Officer and President hereunder without the written consent of the Chief
Executive Officer and President. 
 Section 8. Legal Rights Under ERISA  
 An employee covered under the Plan is entitled to certain rights and protections under the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). ERISA provides that you are entitled to:

 Receive Information About Your Plan and Benefits 
 Examine, without charge, at the Plan Administrator’s office and at other specified locations, such as worksites, all documents governing the Plan, including a copy of the latest annual report (Form 5500 Series),
if any, filed by the Plan with the U.S. Department of Labor and available at the Public Disclosure Room of the Employee Benefits Security Administration. 
 Obtain, upon written request to the Plan Administrator, copies of documents governing the operation of the Plan, including copies of the latest annual report (Form 5500 Series), if any, and updated summary plan
description. The Plan Administrator may make a reasonable charge for the copies. 
  

 9 

 Receive a summary of the Plan’s annual financial report (if any). The Plan Administrator is required
by law to furnish each participant with a copy of this summary annual report. 
 Prudent Actions by Plan Fiduciaries 
 In addition to creating rights for Plan participants, ERISA imposes duties upon the people who are responsible for the operation of the Plan. The people
who operate the Plan, called “fiduciaries” of the Plan, have a duty to do so prudently and in the interest of the Plan participants and beneficiaries. No one, including the employer or any other person, may fire an employee or otherwise
discriminate against an employee in any way to prevent such employee from obtaining a welfare benefit or exercising such employee’s rights under ERISA. 
 Enforce Rights 
 If a claim for a welfare benefit is denied or ignored, in whole or in part, the
claimant has a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules. 
 Under ERISA, there are steps an employee can take to enforce the above rights. For instance, if an employee makes a written request for a copy of Plan
documents or the latest annual report from the Plan Administrator and does not receive them within 30 days, the employee may file suit in a Federal court. In such a case, the court may require the Plan Administrator to provide materials and pay the
employee up to $110 a day until the employee receives the materials, unless the materials were not sent because of reasons beyond the control of the Plan Administrator. 
 If an employee has a claim for benefits that is denied or ignored, in whole or in part, the employee may file suit in a state or Federal court. If it should happen that Plan fiduciaries misuse the Plan’s money or
if an employee is discriminated against for asserting his or her rights, such employee may seek assistance from the U.S. Department of Labor, or such employee may file suit in a Federal court. The court will decide who should pay court costs and
legal fees. If the employee is successful, the court may order the person sued to pay these costs and fees. If the employee loses, the court may order the employee to pay these costs and fees, for example, if it finds the employee’s claim is
frivolous. 
 An employee who has any questions about the Plan should contact the Plan Administrator. An employee who has any questions about this statement
or his or her rights under ERISA should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in the telephone directory, or the Division of Technical Assistance and Inquiries, Employee
Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, N.W., Washington, D.C. 20210. 
  

 10 

 Section 9. Other Important Information 
 9.1 No Additional Rights Created. Neither the establishment of this Plan, nor any modification thereof, nor the payment of any benefits hereunder, shall be construed as giving to any individual (or any
beneficiary of either), or other person any legal or equitable right against the Company, or any of its affiliates, or any officer, director or employee thereof; and in no event shall the terms and conditions of employment by the Company (or any
affiliate) of any individual be modified or in any way affected by this Plan. 
 9.2 Records. The records of the Company with respect to the
determination of Eligible Years of Service, employment history, Base Pay, absences, and all other relevant matters shall be conclusive for all purposes of this Plan. 
 9.3 Construction. The Plan is intended to be governed by ERISA. The respective terms and provisions of the Plan shall be construed, whenever possible and for all purposes, to be in conformity with the
requirements of ERISA, or any subsequent laws or amendments thereto. To the extent not in conflict with ERISA or the terms of the Plan, the construction and administration of the Plan shall be in accordance with applicable federal law and the laws
of the State of California applicable to contracts made and to be performed within the State of California (without application of California conflict of laws provisions). 
 9.4 Nontransferability of Benefits Rights. In no event shall the Company make any payment under this Plan to any assignee or creditor of an employee, except as otherwise required by law. Prior to the time of a
payment hereunder, an employee shall have no rights by way of anticipation or otherwise to assign or otherwise dispose of any interest under this Plan, nor shall rights be assigned or transferred by operation of law. 
 9.5 Plan Interpretation and Benefit Determination. The Plan is administered and operated by the Plan Administrator, which has complete authority, in such person
or entity’s sole and absolute discretion, to construe and interpret the terms of the Plan (and any related or underlying documents or policies), and to determine the eligibility for, and amount of, benefits due under the Plan. All such
interpretations and determinations of the Plan Administrator shall be final and binding upon all parties and persons affected thereby. The Plan Administrator may appoint one or more individuals and delegate such of its powers and duties with respect
to this Plan as it deems desirable to any such individual(s), in which case every reference herein made to the Plan Administrator shall be deemed to mean or include the appointed individual(s) as to matters within their jurisdiction as delegated by
the Plan Administrator. The discretion and authority of the Plan Administrator under this Section 9.5 is subject to the notice, claims and appeals procedures set forth in Section 6. 
  

 11 

 Section 10. Important Plan Information  
  

			
	Sponsor’s Name and Address:	 	Nektar Therapeutics
		 	150 Industrial Road
		 	San Carlos, CA 94070
		
	Plan Number:	 	503
		
	Employer Identification Number:	 	94-3134940
		
	Plan Administrator:	 	Nektar Therapeutics
		 	150 Industrial Road
		 	San Carlos, CA 94070
		 	Tel: 650-631-3100
		
		 	 The Plan Administrator has delegated day-to-day
 administration of the Plan to the following person:
 Vice President, Human Resources

		
	Agent to Receive Process:	 	Nektar Therapeutics
		 	150 Industrial Road
		 	San Carlos, CA 94070
		 	Attn: General Counsel
		
	Type of Plan:	 	 The Plan is an unfunded employee welfare benefit plan.
 Benefits under the Plan are paid from the general assets of
 Nektar Therapeutics. Benefits under the Plan are not
 insured by the Pension Benefit Guaranty Corporation.

		
	Effective Date:	 	January 1, 2007
		
	Plan Year:	 	The calendar year, from January 1 to December 31.

  

 12Band Translation Switch Technology License Agreement

 Exhibit 10.33 
 November 7, 2007 
 Band Translation Switch Technology License Agreement 
 This BAND TRANSLATION SWITCH TECHNOLOGY LICENSE
AGREEMENT (this “Agreement”) is entered into as of November 7, 2007 (the “Effective Date”) by and between ENTROPIC COMMUNICATIONS,
INC., a Delaware corporation, having its principal place of business in San Diego, California (“Entropic Communications”), and ECHOSTAR TECHNOLOGIES
CORPORATION, a Delaware corporation, having its principal place of business in Englewood, Colorado (“EchoStar Technologies”). As used herein, Entropic and EchoStar are referred to herein
individually as a “Party” and collectively as the “Parties.”  
 RECITALS 

WHEREAS, EchoStar design and deploys satellite systems for televisions, set-top boxes used to interface between satellite
antennas receiving visual and voice content from satellites and to decode such signals to video signals displayed on video media; 
 WHEREAS, Entropic designs and provides semiconductor devices that enable tuning signals received at the satellite antenna and delivering the tuned signal to the set-top box deployed by EchoStar;

 WHEREAS, each Party owns certain intellectual property related to band translation switch technology; 
 WHEREAS, Entropic desires to receive from EchoStar, and EchoStar is willing to grant to Entropic, a license to certain band
translation switch technology under the terms and conditions of this Agreement; and 
 WHEREAS, EchoStar desires to
receive from Entropic, and Entropic is willing to grant to EchoStar, a commitment to license certain patents related to the band translation switch technology under the terms and conditions of this Agreement; 
 NOW THEREFORE, in consideration of the mutual covenants and agreements set forth below, and for other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 
 AGREEMENT 
 1. DEFINITIONS. As used in this Agreement: 
 1.1 “Affiliate” of a given entity means any person or entity that directly or indirectly Controls, is Controlled by, or is under common
Control with such given entity, for so long as such Control exists, and includes any entity that becomes an Affiliate during the term of this Agreement. For example, EchoStar Communications Corporation is an Affiliate of EchoStar, and RF Magic, Inc.
is an Affiliate of Entropic. 

 November 7, 2007 
  

 1.2 “BTS Product” means any product embodying the BTS Technology, including but not
limited to, integrated circuit devices, chipsets, software, or systems. 
 1.3 “BTS Technology” means the band translation
switch technology as further described in Exhibit A AND Exhibit B, AND as described or claimed in the Entropic BTS Patents identified, in Exhibit C and all continuations, continuations-in-part, applications requesting continuing
examination, divisionals, reexaminations, reissues, and extensions thereof, and foreign counterparts, and substitutions thereof, whether or not the patents are yet issued or the patent applications are yet filed. 
 1.4 “Control” or “Controlled” means direct or indirect ownership by the given person or entity of more than fifty
percent (50%) of the Voting Power or the power to direct or cause the direction of the day-to-day management, operations, business, and policies of the controlled entity, whether through the ownership of voting securities, by contract, or
otherwise. 
 1.5 “CSS System” means any Direct Broadcast Satellite (“DBS”) system employing a CSS Product.

 1.6 “EchoStar” means EchoStar Technologies and its Subsidiaries. 
 1.7 “EchoStar BTS IP” means (i) EchoStar BTS Patents, and (ii) the Intellectual Property Rights in EchoStar BTS Technology.

 1.8 “EchoStar BTS Patents” means any and all design models, patents and patent applications owned by EchoStar or licensed
to EchoStar with the right to sublicense, claiming any rights to any invention conceived prior to the Effective Date and covering BTS Technology, and used and/or implemented by Entropic to develop or manufacture any BTS Products for EchoStar, and
all continuations, continuations-in-part, applications requesting continuing examination, divisionals, reexaminations, reissues, and extensions thereof, and foreign counterparts, and substitutions thereof, whether or not the patents are yet issued
or the patent applications are yet filed. 
 1.9 “EchoStar BTS Technology” means any copyrights, data, know-how,
trade secrets, methods, processes, techniques, proprietary information, specifications, schematics, diagrams, algorithms, software, firmware, and other forms of technology pertaining to BTS Technology, owned by EchoStar or licensed to EchoStar with
the right to sublicense, which existed prior to the Effective Date and EchoStar has provided to Entropic or enabled Entropic to access and use and/or implement solely for the purpose of developing and/or manufacturing any BTS Product for sole use by
EchoStar and EchoStar’s designees. 
 1.10 “Entropic” means Entropic Communications and its Subsidiaries.

 1.11 “Entropic BTS Patents” means any and all design models, patents and patent applications owned by Entropic or its
Subsidiaries or licensed to Entropic or its Subsidiaries with the right to sublicense, claiming any invention conceived prior to the Effective Date and commercially reasonable to practice the BTS Technology, and all continuations,
continuations-in-part, applications requesting continuing examination, divisionals, reexaminations, reissues, and extensions thereof, and foreign counterparts, and substitutions thereof, whether or not the patents are yet issued or the patent
applications are yet filed.  
  

 Page 2 of 16 

 November 7, 2007 
  

 1.12 “Intellectual Property Rights” means all rights of the following types which
may exist or be created under the laws of any jurisdiction in the world: (i) rights associated with works of authorship, including exclusive exploitation rights, copyrights, and mask work rights; (ii) trade secret rights not protected by
one or more unpublished patent applications; and (iii) rights in or relating to registrations and applications for any of the rights referred to in clauses (i) through (iii) of this sentence. For purpose of clarity and conciseness,
Intellectual Property Rights do not include patent rights in any technology which is presently or in the future covered by one or more claims in an EchoStar BTS Patents. Any patent rights, if any, granted to such patent claims are covered by the
definition of EchoStar BTS Patents. 
 1.13 “Purpose” shall mean the providing of BTS Products only to EchoStar directly or
indirectly for any use or purpose by EchoStar and its Affiliates, Subsidiaries and designees. 
 1.14 “Subsidiary” of a
given entity means any entity that is directly or indirectly Controlled by such given entity, for so long as such Control exists, and includes any entity that becomes a Subsidiary during the term of this Agreement. 
 1.15 “Voting Power” means the right to exercise voting power with respect to the election of directors or similar managing authority of
an entity (whether through direct or indirect beneficial ownership of shares or securities of such entity or otherwise). 
 2. LICENSE 

 2.1 EchoStar BTS IP. Subject to the terms and conditions of this Agreement and on behalf of itself, EchoStar hereby grants to
Entropic a worldwide, non-transferable (except as permitted under Section 7.1), non-exclusive, non-sublicensable, fully-paid, royalty-free, terminable license under the EchoStar BTS IP to use, make derivatives of, combine, transform in any way,
and manipulate in order to develop, make, have made, use, sell, offer for sale, import, or export any BTS Products solely for the Purpose. The license granted in this Section is retroactive and prospective. 
 2.2 Exclusivity. Entropic agrees that it will not make, have made, import, export, sell, have sold, use or otherwise dispose of any BTS Products
to the specifications attached as Exhibit B (the “Current BTS Products”) for use in any deployment, system, CSS System, implementation or otherwise other than by EchoStar and EchoStar’s Affiliates, Subsidiaries and designees.
Restrictions on any BTS Products that Entropic may develop in the future, if any, will be governed by the terms and conditions of a future product development, product purchase or similar agreement, which may be entered into between the Parties.

 2.3 Contractors. The licenses granted under Section 2.1 shall extend to contractors of Entropic or its Affiliates, but solely
to the extent such contractors are developing any BTS Products on behalf of Entropic for the purpose of the exclusivity specified in Section 2.2. 
 2.4 Signal Theft. With respect to signals transmitted by Echostar, its Affiliates, Subsidiaries or designees, Entropic shall not directly or knowingly assist any third party, with respect to EchoStar signal:
(i) engage in any signal theft, piracy or similar activities; (ii) engage in any unauthorized reception, transmission, publication, use, display or similar activities with respect to EchoStar programming; (iii) alter any system
utilizing a BTS Product or smart cards or any other equipment compatible with programming delivered by EchoStar or any of its 

  

 Page 3 of 16 

 November 7, 2007 
  

 
Subsidiaries or Affiliates to be capable of signal theft (or for any other reason without the express written consent of EchoStar); (iv) manufacture,
import, offer to the public, sell, provide or otherwise traffic in any technology, product, service or device which is primarily designed or produced for the purpose of, or is marketed for use in, or has a limited commercially significant purpose
other than, assisting in or facilitating signal theft or other piracy; or (v) aid any others in engaging in, or attempting to engage in, any of the above described activities. Entropic shall promptly notify EchoStar if it becomes aware of
any such activity by any person or entity.
 2.5 Notice of Signal Theft. Upon EchoStar providing Entropic with written notice (for
purpose of this Section 2.5 only, the “Notice”) and sufficient evidence establishing at least probable cause that a customer to whom Entropic is selling or otherwise providing BTS Technology or BTS Products is directly or indirectly
engaged in Signal Theft, Entropic will discontinue its sale of or other disposition of BTS Products to such customer within ten (10) business days after receiving such notice and evidence. For purposes of this Section 2.5, Entropic’s
obligation to remedy such breach shall be fully satisfied by: (i) discontinuing sales to the distribution point from which alleged Signal Theft related sales or activities are emanating; (ii) informing said distribution point that further
distribution of any CSS Products provided by Entropic to said customer, are unauthorized and must cease immediately; (iii) providing written notice to EchoStar within fifteen (15) business days of receiving the Notice of the actions it has
taken in response to the Notice; (iv) taking commercially reasonable efforts to cooperate and assist EchoStar in further investigating and prosecuting the Signal Theft allegations; and (v) Entropic shall not resume sales of BTS Products to
any entity identified in the Notice without EchoStar’s consent. 
 2.6 Entropic BTS Patents. 
 (a) Subject to the terms and conditions of this Agreement and on behalf of itself and its Subsidiaries, Entropic agrees to grant a nonexclusive
license to Entropic BTS Patents, under reasonable and non-discriminatory terms, to a third party designated by EchoStar to enable the third party to make, have made, import, sell, have sold, and export BTS Products for use in any deployments by
EchoStar, its Affiliates, Subsidiaries and designees, provided that this obligation to license to such third party is subject to a reciprocal obligation from such third party to grant a similar license under substantially similar terms to Entropic
and its Subsidiaries. Notwithstanding the foregoing, such license obligation shall be suspended, provided Entropic chooses to use one or more of its Intellectual Property Rights or patent rights to cross-assert against such third party to offset a
claim or action brought by such third party against Entropic or its Subsidiaries for infringement of an Intellectual Property Right or patent right relating to BTS Technology. However, such third party may complete and sell any work-in-progress and
inventory of the BTS Products that exist as of the effective date of suspension and for a period of six (6) months thereafter. Entropic’s obligation, if any, to grant a license to Entropic BTS Patents to a third party designated by
EchoStar to enable a second source for any future BTS Products sold to EchoStar, its Affiliates, Subsidiaries and designees will be governed by the terms and conditions of a future product development, product purchase or similar agreement, which
may be entered into between the Parties. 
 (b) To the extent Entropic files for bankruptcy protection under applicable bankruptcy laws
or makes an assignment for the benefit of the creditors (“Bankruptcy”), Entropic agrees to grant a nonexclusive, non-transferable (except as permitted under Section 6.1), fully-paid, and royalty-free license to Entropic BTS
Patents to EchoStar to develop, make, 

  

 Page 4 of 16 

 November 7, 2007 
  

 
have made, use, sell, offer for sale, and import BTS Products, including the right to sublicense a third party designated by EchoStar to supply the BTS
Products solely to EchoStar, its Affiliates and Subsidiaries and designees in furtherance of the Purpose. During the period of time that Entropic is in Bankruptcy, EchoStar will have no obligation to charge any license fees or royalties to such
third party sublicensee. However, at any time Entropic reverts back from Bankruptcy, the license granted to EchoStar under this Section 2.5(b), including any sublicense granted thereunder, will automatically terminate, provided that
Entropic’s obligation to grant a license to a third party under Section 2.5(a) will remain, and EchoStar will have no obligation to pay Entropic any royalties or license fees for the period of time that Entropic was in Bankruptcy.

 3. REPRESENTATIONS AND WARRANTIES 
 3.1 Power and Authority. Each Party represents and warrants that: (i) it has full right, power, and authority to enter into this Agreement and
to perform its obligations and duties under this Agreement, including granting of the license granted in this Agreement, and to bind its Affiliates and or Subsidiaries referenced in this Agreement; (ii) the performance of such obligations and
duties does not and will not conflict with or result in a breach of any other agreements to which it is a party or any judgment, order, or decree by which it is bound; and (iii) it has taken all necessary corporate actions to enter into this
Agreement, and it has duly executed and delivered this Agreement. 
 3.2 Entropic BTS Patents. Entropic represents and warrants that
the patents and patent applications listed on Exhibit C are the only patents and patent applications owned by Entropic or its Subsidiaries as of the Effective Date that cover the BTS Products and are necessary for implementation of the BTS
Technology as shown in Exhibit A of this Agreement. 
 3.3 Entropic Products. Entropic represents and warrants that Exhibit B lists
all of Entropic’s BTS Products as of the Effective Date. 
 3.4 General Disclaimers. THE EXPRESS WARRANTIES SET FORTH IN SECTION
4.1 ARE THE ONLY WARRANTIES MADE BY EITHER PARTY IN CONNECTION WITH THIS AGREEMENT AND ARE IN LIEU OF ALL OTHER WARRANTIES, EXPRESS, IMPLIED, OR STATUTORY. ALL PATENTS AND OTHER INTELLECTUAL PROPERTY RIGHTS LICENSED HEREUNDER ARE PROVIDED “AS
IS.” 
 4. TERM AND TERMINATION 
 4.1 Term. This Agreement shall commence on the Effective Date and shall continue until the latter of: (a) for as long as Entropic is
developing or supplying any BTS Products to EchoStar, its Affiliates, Subsidiaries and designees; and (b) to the end of life of the last to expire of the Entropic BTS Patents and the EchoStar BTS Patents. Further, if Entropic violates
Section 2.5, EchoStar may terminate this Agreement by written notice to Entropic, unless Entropic remedies the violation within thirty (30) calendar days after receiving written notice of such violation. For purposes of this
Section 4.1, Entropic’s obligation to remedy shall be fully satisfied by discontinuing sales to the distribution point from which alleged piracy related sales are emanating. Entropic shall not resume sales to such entity without
EchoStar’s consent. If Entropic misappropriates any EchoStar Intellectual Property Rights disclosed or access provided to Entropic after the Effective Date, EchoStar may terminate this Agreement by written notice to Entropic, unless Entropic
remedies the violation with ninety (90) days after receiving written notice of such violation. 
  

 Page 5 of 16 

 November 7, 2007 
  

 4.2 Effect of Termination. Upon termination of this Agreement for violations under Section and
2.5, the license granted by EchoStar to Entropic hereunder shall immediately terminate. Upon termination of this Agreement for any other reason, the license granted by EchoStar to Entropic hereunder shall immediately terminate, except Entropic may
complete and sell any work-in-progress and inventory of the BTS Products to fulfill any outstanding purchase orders submitted by EchoStar, its Affiliates, Subsidiaries or designees. 
 4.3 Survival. Sections 1 (Definitions), 2.5 (Notice of Signal Theft), 3 (Representations and Warranties), 4.2 (Effect of Termination), 4.3
(Survival), 5 (Limitation of Liability), 6 (Confidentiality) and 7 will survive any termination of this Agreement. 
 5. LIMITATION
ON LIABILITY. EXCEPT AS OTHERWISE PROVIDED EXPRESSLY HEREIN, NEITHER ECHOSTAR NOR ENTROPIC WILL BE LIABLE TO THE OTHER FOR INCIDENTAL, INDIRECT, CONSEQUENTIAL, SPECIAL, PUNITIVE OR EXEMPLARY DAMAGES OF ANY KIND
(INCLUDING LOST REVENUES OR PROFITS, OR LOSS OF BUSINESS) IN ANY WAY RELATED TO THIS AGREEMENT, REGARDLESS OF WHETHER THE PARTY LIABLE OR ALLEGEDLY LIABLE WAS ADVISED, HAD OTHER REASON TO KNOW, OR IN FACT KNEW OF THE POSSIBILITY THEREOF. THE
FOREGOING LIMITATIONS OF LIABILITY SHALL NOT APPLY FOR ANY REASON WHATSOEVER IN CONNECTION ANY WILLFUL MISCONDUCT OR GROSS NEGLIGENCE OF EITHER PARTY. 
 (a) For the purpose of this Section 5 only, references to “EchoStar” and Entropic” shall be deemed to include each Party’s employees, directors, officers, licensees, representatives and
subcontractors, suppliers, distributors and customers. 
 6. CONFIDENTIALITY. Neither Party shall disclose any confidential information
to the other Party under this Agreement. 
 7. GENERAL 
 7.1 Restriction on Assignment. Neither Party may assign or transfer this Agreement or any of its rights and obligations under this Agreement to any third party without the prior written notice to, and obtaining
the prior written consent of, the other Party; provided however that (i) EchoStar may assign this Agreement, without such consent of Entropic, to an Affiliate of EchoStar or to a third party, other than a direct competitor of Entropic (or any
Affiliate of such a direct competitor), in connection with the sale of all or substantially all of the business and assets of EchoStar relating to this Agreement, whether by sale, merger, operation of law or otherwise, and (ii) Entropic may
assign this Agreement, without such consent of EchoStar, to an Affiliate of Entropic or to a third party, other than a direct competitor of EchoStar (or any Affiliate of such a direct competitor), in connection with the sale of all or substantially
all of the business and assets of Entropic relating to this Agreement, whether by sale, merger, operation of law or otherwise. Any assignment or attempted assignment in violation of the foregoing will be null and void. In the event of any assignment
of this Agreement, the successor-in-interest must agree in writing to be bound by the terms and conditions of this Agreement. 
  

 Page 6 of 16 

 November 7, 2007 
  

 7.2 Infringement by Others. Each Party shall have the option, but not the obligation, to seek
redress for infringement of any each Party’s patent rights in BTS Technology by third parties at its own expense and shall be entitled to any recovery therefore. In any action for such infringement, the other Party shall reasonably cooperate
with the asserting Party at the asserting Party’s reasonable expense. Neither Party shall have any right, authority or standing to bring any action against any third party relating to the third party’s infringement of the other
Party’s patent rights in and/or to the BTS Technology. 
 7.3 Confidentiality of the Agreement. Neither Party will disclose any
terms or conditions of this Agreement to any third party, without the prior written consent of the other Party, except (i) as required by laws or regulations, including SEC regulations; (ii) to its attorneys, accountants, and other
professional advisors under a duty of confidentiality; or (iii) to a third party under a duty of confidentiality in connection with a proposed merger or a proposed sale of all or part of such Party’s business which relates to this
Agreement. 
 7.4 Notice. Any notice, approval, authorization, consent, or other communication required or permitted to be delivered
to any Party under this Agreement must be in writing and will be deemed properly delivered, given, and received (i) one (1) business day after it is sent for overnight delivery by a nationally recognized courier or express delivery service
as evidenced by receipt of such courier or service, or (ii) on the date of facsimile transmission confirmed by mailing a copy thereof to the address or facsimile number set forth beneath the name of such Party below (or to such other address or
facsimile number as such Party may have specified in a written notice to the other Party): 
  

			
	If to EchoStar:	  	If to Entropic:
		
	 EchoStar Technologies Corporation
 9601 S. Meridian Blvd.
 Englewood, CO 80112
 Phone: (303) 723-1600
 FAX: (303) 723-1699
 Attention: General Counsel
	  	 Entropic Communications
 9276 Scranton Road, Second Floor
 San Diego, CA 92121
 Phone: 858-625-3200
 Fax: 858-546-2409
 Attention: General Counsel

 7.5 Governing Law; Venue. This Agreement will be construed in accordance with and governed
in all respects by the laws of the State of Delaware without regard to any conflicts of law principles which would result in application of laws of any other jurisdiction. Any legal action or other legal proceeding relating to this Agreement, the
subject matter thereof or the enforcement of any provision of this Agreement may only be brought or otherwise commenced in the state or federal courts located in Wilmington, Delaware. Each Party expressly and irrevocably consents and submits to the
jurisdiction of such state and federal courts (and appellate courts thereof in connection with any such legal proceeding). 
 7.6
Waiver. All waivers must be in writing and signed by an authorized representative of the Party to be charged. Any waiver or failure to enforce any provision of this Agreement on one occasion will not be deemed a waiver of any other provision or
of such provision on any other occasion. 
  

 Page 7 of 16 

 November 7, 2007 
  

 7.7 Severability. If any provision of this Agreement is unenforceable, such provision will be
changed and interpreted to accomplish the objectives of such provision to the greatest extent possible under applicable law and the remaining provisions will continue in full force and effect. 
 7.8 Independent Contractors. This Agreement is not intended to establish any partnership, joint venture, agency, or other relationship between the
Parties, except that of independent contractors. 
 7.9 Construction. The section headings in this Agreement are for convenience of
reference only, will not be deemed to be a part of this Agreement, and will not be referred to in connection with the construction or interpretation of this Agreement. Any rule of construction to the effect that ambiguities are to be resolved
against the drafting Party will not be used against either Party in the construction or interpretation of this Agreement. As used in this Agreement, the words “include” and “including,” and variations thereof, will not be deemed
to be terms of limitation, but rather will be deemed to be followed by the words “without limitation.” All references in this Agreement to “Sections” are intended to refer to Sections of this Agreement. 
 7.10 Counterparts. This Agreement may be executed in several counterparts, each of which will constitute an original and all of which, when taken
together, will constitute one agreement. 
 7.11 Entire Agreement. This Agreement sets forth the entire understanding of the Parties
relating to the subject matter hereof and supersedes all prior agreements and understandings between the Parties relating to the subject matter hereof. This Agreement may not be amended, modified, altered, or supplemented other than by means of a
written instrument duly executed and delivered on behalf of all Parties. 
 IN WITNESS WHEREOF, the Parties have executed this Agreement as
of the Effective Date. 
  

									
	ENTROPIC COMMUNICATIONS, INC.	 		 	ECHOSTAR TECHNOLOGIES CORPORATION
					
	By:	 	 /s/ Patrick Henry
	 		 	By:	 	 /s/ Mark W. Jackson

	Name:	 	Patrick Henry	 		 	Name:	 	Mark W. Jackson
	Title:	 	Chief Executive Officer	 		 	Title:	 	President

  

 Page 8 of 16 

 November 7, 2007 
  

 Exhibit A 
 BTS TECHNOLOGY 
 Any technology that performs the functionality as shown in the diagram within the
dashed box of the figure on the page titled “6 .0 BLOCK DIAGRAM” of specification titled Band Translating Switch RF Specification BTS Rev 00 dated September 19, 2001 (attached for reference). 
 Filters and combiner may or may not be part of IC Device due to the ability to integrate these components, however, these will be part of the overall solution.

 Furthermore 
 Filter bandwidth is greater than
500 MHz 
 Number of inputs greater than or equal to 2 
 Number of Band Translation devices greater than or equal to 2 
 May or may not have cascade outputs.

 Entropic’s RF5000, RF5100, RF5101 are product examples that perform this functionality. 

 November 7, 2007 
  

 

 
  

 November 7, 2007 
  

 EXHIBIT B 
 ENTROPIC BTS PRODUCT SPECIFICATIONS 
 

 
  

 1 

 November 7, 2007 
  

 

 
  

 2 

 November 7, 2007 
  

 

 
  

 3 

 November 7, 2007 
  

 

 
  

 4 

 November 7, 2007 
  

 

 
  

 5 

 November 7, 2007 
  

 Exhibit C 
 ENTROPIC BTS PATENTS 
  

									
	 DOCKET
	 	 TITLE
	 	 Country
	 	 Patent Number
	 	 Application Serial Number

	 RFM001B
 US

	 	Integrated Crosspoint Switch with Band Translation	 	US	 		 	 11/618,922
 (US20070111661 Pub. No)

					
	 RFM001
 EP

	 	Integrated Crosspoint Switch with Band Translation	 	EPO	 		 	 EP20030797006
 (EP1573931 Pub.
No.)

					
	 RFM001
 CN

	 	Integrated Crosspoint Switch with Band Translation	 	China	 		 	 CN20038108801
 (CH1739245A Pub.
No.)

					
	 RFM002B
 US

	 	 Signal Distribution
 System
	 		 		 	 11/538,627
 (US20070141982 Pub. No.)

		 	 Cascadable AGC
 Device and
	 	US	 		 
		 	Method	 		 		 
					
	 RFM002
 EP

	 	 Signal Distribution
 System
 Cascadable AGC
 Device and
 Method
	 	EPO	 		 	 EP20030812996
 (EP1576751A2 Pub. No.)

					
	 RFM002
 CN

	 	 Signal Distribution System
 Cascadable AGC
 Device and
 Method
	 	China	 		 	 CN20038108717
 (CN1739252A Pub.
No.)

					
	 RFM003B
 US

	 	 NxM Crosspoint Switch
 w/ Band Translation
	 	US	 		 	 11/537,628
 (US20070087712 Pub. No.)

					
	 RFM003
 EP

	 	NxM Crosspoint Switch w/ Band Translation	 	EPO	 		 	 EP20030790493
 (EP1574084A2 Pub.
No.)

					
	RFM004B	 	Mixer Circuit with Bypass	 		 		 	
		 	and Mixing Modes having	 		 		 	
		 	Constant Even Order	 	US	 	7,271,640	 	
		 	Generation and Method of	 		 		 	
		 	Operation	 		 		 	

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]